Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 6, 2024; 12(28): 6244-6246
Published online Oct 6, 2024. doi: 10.12998/wjcc.v12.i28.6244
Old, the new, more or less and the conundrum for biomarkers in cardiovascular diseases?
Pupalan Iyngkaran
Pupalan Iyngkaran, Department of Cardiology, Notre Dame University, Werribee 3029, Australia
Pupalan Iyngkaran, Department of Public Health, Torrens Univeristy Australia, Melbourne 3004, Victoria, Australia
Author contributions: Iyngkaran P wrote the paper.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Pupalan Iyngkaran, FRACP, Senior Lecturer, Staff Physician, Cardiology, Notre Dame University, Melbourne Medical School, Werribee 3029, Australia. pupalan.iyngkaran@students.torrens.edu.au
Received: May 29, 2024
Revised: July 20, 2024
Accepted: August 2, 2024
Published online: October 6, 2024
Processing time: 75 Days and 8.6 Hours
Core Tip

Core Tip: Biomarkers are among a few pillars of medical care however caution is raised and encouragement is provided for observations into biomarker studies. Combination of biomarkers are a novel method and may increase the appeal of single biomarkers. Design of experiments to evaluate biomarkers and diseases are as important as the specific biomarkers being tested.